SCHEDULE Filed 2026-01-29 Event 2025-10-21 SEC 0001829126-26-000773 →

Lazar David E. → NovaBay Pharmaceuticals, Inc. SDEV

Stake: 4.99% Shares: 6,388,000 CUSIP: 66987P409 Class: Common Stock, $0.01 par value

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 27/100 · Filer 90d Win Rate: 67% · Hist. 90d Edge: +132.4%

Filer track record (4 filings): 67% 90d win rate, +132.4% 90d edge

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

17 13D/G filings on this issuer

16 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

1,272,208 shares short · -63.0% vs prior

Post-Filing Returns · since 2025-10-21 on SDEV

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 1.25 on closest trading day on/after 2025-10-21. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on NovaBay Pharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2026-10-29	SCHEDULE 13D/A	Sky Frontier Foundation	—	8,115,087	view →
2026-08-21	SCHEDULE 13D/A	Sky Frontier Foundation	9.90%	5,617,689	view →
2026-07-24	SCHEDULE 13D/A	R01 Fund LP	52.40%	49,508,502	view →
2026-07-24	SCHEDULE 13D/A	Framework Ventures IV L.P.	46.60%	47,723,141	view →
2026-07-22	SCHEDULE 13D/A	Sky Frontier Foundation	—	4,000,000	view →
2026-06-17	SCHEDULE 13D/A	R01 Fund LP	49.80%	33,404,510	view →
2026-06-17	SCHEDULE 13D/A	Framework Ventures IV L.P.	45.90%	32,690,366	view →
2026-05-27	SCHEDULE 13D	Sky Frontier Foundation	9.90%	3,009,502	view →
2026-05-22	SCHEDULE 13G	Tether Global Investments Fund, S.I.C.A.F., S.A.	—	—	view →
2026-05-19	SCHEDULE 13D/A	R01 Fund LP	—	33,429,230	view →
2026-05-19	SCHEDULE 13D/A	Framework Ventures IV L.P.	—	32,715,086	view →
2026-01-21	SCHEDULE	Framework Ventures IV L.P.	45.00%	56,806,080	view →
2026-01-21	SCHEDULE	R01 Fund LP	45.00%	56,806,080	view →
2020-08-24	SC	Fu Jian Ping	—	—	view →
2019-04-16	SC	Fu Jian Ping	—	—	view →
2019-04-16	SC	OP Financial Ltd	—	—	view →

Other Filings by Lazar David E.

Filed	Form	Issuer	Stake	Shares
2026-09-29	SCHEDULE 13D/A	Aterian, Inc.	3.10%	8,038,030	view →
2026-09-10	SCHEDULE 13D	Aterian, Inc.	95.70%	249,900,000	view →
2026-08-07	SCHEDULE 13D/A	Quantum Cyber N.V.	94.30%	477,000,000	view →
2026-07-02	SCHEDULE 13D/A	KALA BIO, Inc. KALA	3.90%	719,404	view →
2026-04-28	SCHEDULE 13D	MAINZ BIOMED N.V. QUCY	97.40%	477,000,000	view →
2025-03-10	SCHEDULE	FiEE, Inc. FIEE	35.10%	2,802,254	view →
2024-04-08	SC	OPGEN INC CFOR	—	—	view →
2022-07-11	SC	EQUUS TOTAL RETURN, INC. EQS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →